Europe News
Most Popular Europe Story
From Iceland's woes, an $8B Actavis deal?
If Iceland's financial crisis was an earthquake, then this is a major aftershock: Actavis Group, one of the world's biggest generics makers, may go on the block for as much as $8 billion. Actavis is... Read more...
Latest Headlines
- January 15, 2010
- October 1, 2009
- August 26, 2009
- July 16, 2009
- July 8, 2009
- July 8, 2009
- July 6, 2009
- April 29, 2009
- March 19, 2009
- February 20, 2009
- December 11, 2008
- November 25, 2008
- November 14, 2008
- October 17, 2008
- October 16, 2008
- September 17, 2008
- June 27, 2008
- May 15, 2008
- May 2, 2008
- April 29, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
